BioXcel Therapeutics BTAIQ
OTC BTAIQ
$0.05 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

BioXcel Therapeutics (BTAIQ) Return on Capital Employed [ROCE] (2018 - 2025)

Updated

BioXcel Therapeutics (BTAIQ) posted Return on Capital Employed [ROCE] of -412.06% for Q1 2025, down 100.99 percentage points from -311.08% a year earlier and down 97.57 percentage points from the prior quarter.

Analysis

BioXcel Therapeutics (BTAIQ) Return on Capital Employed [ROCE] (2018 - 2025) Analysis & Trends

For FY2024, BioXcel Therapeutics' Return on Capital Employed [ROCE] came in at -199.03%, down 46.35 percentage points from FY2023.

  • Annual Return on Capital Employed [ROCE] has declined for three consecutive years, with a five-year change of -92.36 percentage points (FY2019 to FY2024).
  • In prior years, BioXcel Therapeutics' Return on Capital Employed [ROCE] was -152.68% in FY2023 (-68.55 pp), -84.14% in FY2022 (-33.94 pp), -50.20% in FY2021 (+20.55 pp) and -70.75% in FY2020 (+35.91 pp).
  • The Q1 2025 figure stands as the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q1 2018.
  • On a year-over-year basis, Return on Capital Employed [ROCE] increased in 1 of the last eight quarters, with an average year-over-year change of -111.87 percentage points.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q4 2020, with a gain of 68.57 percentage points; the weakest was Q4 2023, with a drop of 204.26 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -314.49% (Q4 2024), -242.44% (Q3 2024) and -235.31% (Q2 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 BioXcel Therapeutics 1.57 Mn 1.57 Mn 160,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -412.06%
Dec 31, 2024 -314.49%
Sep 30, 2024 -242.44%
Jun 30, 2024 -235.31%
Mar 31, 2024 -311.08%
Dec 31, 2023 -287.22%
Sep 30, 2023 -253.27%
Jun 30, 2023 -155.95%
Mar 31, 2023 -109.23%
Dec 31, 2022 -82.96%
Sep 30, 2022 -59.55%
Jun 30, 2022 -57.58%
Mar 31, 2022 -53.54%
Dec 31, 2021 -45.75%
Sep 30, 2021 -39.71%
Jun 30, 2021 -43.74%
Mar 31, 2021 -47.35%
Dec 31, 2020 -37.84%
Sep 30, 2020 -50.35%
Jun 30, 2020 -87.10%
API Access

BioXcel Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY